Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice.
Heart inflammation caused by the mRNA COVID vaccines is rare. The COVID vaccines have saved millions of lives from a virus that has killed more than seven million people globally. Many safety studies ...
New mRNA vaccine is more effective and less costly to develop. A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results